Kevin Murphy manages the Asia and pharmaceutical practice for New York-based intellectual property boutique lawfirm GS2Law. He is a skilled trial lawyer with over 20 years of experience that includes litigating two dozen cases to successful verdicts.

Previously, Kevin was a prosecutor in the Manhattan District Attorney’s office, where he won 18 bench and jury conviction verdicts during a three-year span. He then worked on product liability litigation for Lowenstein Sandler LLP.  In 2001, Kevin headed to Frommer Lawrence, making partner in 2004 after helping to win a $12 million trade secrets jury verdict for Japanese semiconductor firm Tokyo Electron Ltd. He spent much of the next decade representing his clients in major copyright, patent and trademark litigation.  In addition, Kevin is called upon yearly to address issues of American litigation before law firms and corporate panels in the United States as well as in China.

Kevin’s recent matters include:

• Serving as lead counsel for foreign patentee in an infringement action over optical disk restoration equipment
• Serving as lead counsel for a renowned photographer in a copyright infringement action involving “clickbait” use of copyrighted images of supermodel Bar Refaeli
• Serving as lead counsel for creditor-plaintiff in securities fraud action, securing a critical preliminary injunction following hearing
• Advising and negotiating on behalf of Chinese state-owned enterprise on its in-licensing of PDA-related technology
• Successfully representing a biotech company as lead counsel in an inventorship dispute over anti-diabetic peptide analogs, resulting in favorable settlement of the case for client on eve of trial
• Successfully representing a generics client in ANDA challenge to 7 patents covering the drug Niaspan, resulting in a highly favorable settlement of the matter for his client

Fudan University, Mandarin Chinese
China Institute, Mandarin Chinese, 2008
George Washington National Law Center, (J.D.) 1994, Cum Laude
Ursinus College, (B.A. Politics and English) 1991, Magna Cum Laude

“Calling the Truce: Leveraging IP Positions While Litigating,” Licensing and Alliances in the Generics Industry, Berlin, Germany, May 2007

“US Pharmaceutical and Regulatory Procedures: An Overview,” & “Panel Discussion on Antitrust Consequences of Settling Patent Litigation,” Legal Strategies for Developing Generic Medicines, Amsterdam, Netherlands, July 2007

NYIPLA Bulletin April/May 2012: Maintaining Surprise in a Patent Case BioPharm International December 2012: Patent and Postapproval Batch Testing